vs

Side-by-side financial comparison of Seven Hills Realty Trust (SEVN) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.

TriSalus Life Sciences, Inc. is the larger business by last-quarter revenue ($13.2M vs $7.3M, roughly 1.8× Seven Hills Realty Trust). Seven Hills Realty Trust runs the higher net margin — 65.6% vs -73.9%, a 139.5% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs -4.8%). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs -11.7%).

Seven Hills Realty Trust is a publicly traded real estate investment trust focused on originating, underwriting and managing senior secured mortgage loans backed by commercial real estate assets across the United States. Its core target segments include multifamily residential, industrial, and high-quality commercial office properties.

TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.

SEVN vs TLSI — Head-to-Head

Bigger by revenue
TLSI
TLSI
1.8× larger
TLSI
$13.2M
$7.3M
SEVN
Growing faster (revenue YoY)
TLSI
TLSI
+64.7% gap
TLSI
59.8%
-4.8%
SEVN
Higher net margin
SEVN
SEVN
139.5% more per $
SEVN
65.6%
-73.9%
TLSI
Faster 2-yr revenue CAGR
TLSI
TLSI
Annualised
TLSI
43.0%
-11.7%
SEVN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
SEVN
SEVN
TLSI
TLSI
Revenue
$7.3M
$13.2M
Net Profit
$4.8M
$-9.8M
Gross Margin
86.7%
Operating Margin
65.7%
-24.8%
Net Margin
65.6%
-73.9%
Revenue YoY
-4.8%
59.8%
Net Profit YoY
-1.7%
3.5%
EPS (diluted)
$0.29
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SEVN
SEVN
TLSI
TLSI
Q4 25
$7.3M
$13.2M
Q3 25
$7.1M
$11.6M
Q2 25
$7.4M
$11.2M
Q1 25
$7.6M
$9.2M
Q4 24
$7.7M
$8.3M
Q3 24
$8.9M
$7.3M
Q2 24
$9.4M
$7.4M
Q1 24
$9.4M
$6.5M
Net Profit
SEVN
SEVN
TLSI
TLSI
Q4 25
$4.8M
$-9.8M
Q3 25
$3.4M
$-10.8M
Q2 25
$2.7M
$-8.3M
Q1 25
$4.5M
$-10.4M
Q4 24
$4.9M
$-10.1M
Q3 24
$3.5M
$-2.4M
Q2 24
$4.2M
$-4.3M
Q1 24
$5.2M
$-13.2M
Gross Margin
SEVN
SEVN
TLSI
TLSI
Q4 25
86.7%
Q3 25
83.5%
Q2 25
83.9%
Q1 25
83.7%
Q4 24
85.3%
Q3 24
86.3%
Q2 24
87.6%
Q1 24
85.0%
Operating Margin
SEVN
SEVN
TLSI
TLSI
Q4 25
65.7%
-24.8%
Q3 25
48.3%
-77.9%
Q2 25
36.2%
-65.4%
Q1 25
59.8%
-79.9%
Q4 24
63.6%
-91.8%
Q3 24
39.4%
-118.9%
Q2 24
45.2%
-111.0%
Q1 24
55.9%
-180.8%
Net Margin
SEVN
SEVN
TLSI
TLSI
Q4 25
65.6%
-73.9%
Q3 25
48.4%
-93.5%
Q2 25
36.2%
-73.9%
Q1 25
59.7%
-113.2%
Q4 24
63.6%
-122.4%
Q3 24
39.3%
-32.6%
Q2 24
45.1%
-58.8%
Q1 24
55.9%
-204.5%
EPS (diluted)
SEVN
SEVN
TLSI
TLSI
Q4 25
$0.29
$-0.22
Q3 25
$0.23
$-0.96
Q2 25
$0.18
$-0.27
Q1 25
$0.30
$-0.39
Q4 24
$0.34
$-0.38
Q3 24
$0.23
$-0.12
Q2 24
$0.28
$-0.21
Q1 24
$0.35
$-0.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SEVN
SEVN
TLSI
TLSI
Cash + ST InvestmentsLiquidity on hand
$123.5M
$20.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$328.7M
$-33.9M
Total Assets
$820.9M
$35.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SEVN
SEVN
TLSI
TLSI
Q4 25
$123.5M
$20.4M
Q3 25
$77.5M
$22.7M
Q2 25
$46.0M
$26.5M
Q1 25
$41.6M
$13.0M
Q4 24
$70.8M
$8.5M
Q3 24
$82.2M
$11.3M
Q2 24
$69.6M
$16.5M
Q1 24
$93.3M
$4.0M
Stockholders' Equity
SEVN
SEVN
TLSI
TLSI
Q4 25
$328.7M
$-33.9M
Q3 25
$266.5M
$-26.7M
Q2 25
$267.0M
$-19.4M
Q1 25
$268.9M
$-34.4M
Q4 24
$269.3M
$-25.9M
Q3 24
$269.5M
$-20.4M
Q2 24
$271.1M
$-25.3M
Q1 24
$271.6M
$-36.0M
Total Assets
SEVN
SEVN
TLSI
TLSI
Q4 25
$820.9M
$35.3M
Q3 25
$700.8M
$36.5M
Q2 25
$687.4M
$41.3M
Q1 25
$714.4M
$28.6M
Q4 24
$692.8M
$24.0M
Q3 24
$652.6M
$27.5M
Q2 24
$694.9M
$32.4M
Q1 24
$697.7M
$17.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SEVN
SEVN
TLSI
TLSI
Operating Cash FlowLast quarter
$15.0M
$-2.5M
Free Cash FlowOCF − Capex
$-2.5M
FCF MarginFCF / Revenue
-19.1%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
3.14×
TTM Free Cash FlowTrailing 4 quarters
$-19.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SEVN
SEVN
TLSI
TLSI
Q4 25
$15.0M
$-2.5M
Q3 25
$3.2M
$-3.7M
Q2 25
$5.0M
$-7.3M
Q1 25
$3.7M
$-4.5M
Q4 24
$20.1M
$-5.7M
Q3 24
$7.3M
$-10.8M
Q2 24
$4.2M
$-13.4M
Q1 24
$4.7M
$-10.9M
Free Cash Flow
SEVN
SEVN
TLSI
TLSI
Q4 25
$-2.5M
Q3 25
$-3.9M
Q2 25
$-7.4M
Q1 25
$-5.3M
Q4 24
$-5.8M
Q3 24
$-11.0M
Q2 24
$-13.5M
Q1 24
$-10.9M
FCF Margin
SEVN
SEVN
TLSI
TLSI
Q4 25
-19.1%
Q3 25
-33.9%
Q2 25
-66.1%
Q1 25
-57.3%
Q4 24
-69.7%
Q3 24
-149.9%
Q2 24
-183.1%
Q1 24
-169.3%
Capex Intensity
SEVN
SEVN
TLSI
TLSI
Q4 25
0.3%
Q3 25
1.9%
Q2 25
0.8%
Q1 25
8.2%
Q4 24
0.6%
Q3 24
2.3%
Q2 24
0.8%
Q1 24
1.0%
Cash Conversion
SEVN
SEVN
TLSI
TLSI
Q4 25
3.14×
Q3 25
0.92×
Q2 25
1.86×
Q1 25
0.81×
Q4 24
4.12×
Q3 24
2.10×
Q2 24
1.00×
Q1 24
0.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons